AGM/EGMJun 22, 2026, 11:11 AM
Eupraxia Shareholders Elect Directors, Re-appoint KPMG at AGM
AI Summary
Eupraxia Pharmaceuticals announced the results of its Annual General Meeting of Shareholders held on June 18, 2026. Shareholders approved the election of all seven management-proposed nominees to the Board of Directors. Additionally, KPMG LLP was re-appointed as the company's auditor for the upcoming year, and shareholders authorized the Board to fix the auditors' remuneration. All items of business presented at the meeting were passed with strong shareholder support.
Key Highlights
- All seven management-proposed nominees were elected to the Board of Directors.
- James A. Helliwell received 99.784% of votes in favor for director.
- Simon Pimstone received 91.102% of votes in favor for director.
- Robert Bazemore received 99.975% of votes in favor for director.
- KPMG LLP was re-appointed as auditor with 99.644% of votes in favor.
- Shareholders approved setting the number of directors at seven with 99.983% votes for.
Price Impact
More from EPRX